WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Inc Stock Ownership - Who owns Ligand Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ligand Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Octavio EspinozaCFO2026-08-1216,179$52.84
$854.90kBuy
Jason HaasDirector2026-08-127,138$292.81
$2.09MSell
Jason HaasDirector2026-08-126,138$51.56
$316.48kBuy
Octavio EspinozaCFO2026-08-1231,641$292.07
$9.24MSell
Octavio EspinozaCFO2026-08-123,348$68.74
$230.14kBuy
Octavio EspinozaCFO2026-08-127,171$57.22
$410.32kBuy
Octavio EspinozaCFO2026-08-122,869$55.75
$159.95kBuy
Octavio EspinozaCFO2026-08-122,074$70.04
$145.26kBuy
Andrew ReardonCLO;Sec2026-08-035,000$52.27
$261.35kBuy
Andrew ReardonCLO;Sec2026-08-03409$292.82
$119.76kSell

1 of 19

LGND insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LGND insiders and whales buy or sell their stock.

LGND Shareholders

What type of owners hold Ligand Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P317.70%63,334,719$18.21BInsider
David M. Knott63.26%12,611,277$3.63BInsider
Daniel S. Loeb48.93%9,754,756$2.81BInsider
Investment 10 LLC17.97%3,582,065$1.03BInsider
Goldman Sachs Group Inc3.44%686,330$197.38MInsider
John L. Higgins2.10%417,695$120.12MInsider
Todd C. Davis1.00%199,513$57.38MInsider
Matthew W. Foehr0.81%162,187$46.64MInsider
Jason Aryeh0.73%145,955$41.98MInsider
Martin Meglasson0.51%102,250$29.41MInsider

1 of 3

LGND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LGND0.02%99.98%Net SellingNet Selling
CAI0.05%81.45%Net BuyingNet Buying
TVTX0.11%61.61%Net SellingNet Buying
PTCT0.12%17.28%Net SellingNet Selling
XENE0.10%2.58%Net SellingNet Selling
View Top Biotech Stocks

Ligand Pharmaceuticals Stock Ownership FAQ

Who owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals (NASDAQ: LGND) is owned by 0.11% institutional shareholders, 459.78% Ligand Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Ligand Pharmaceuticals shareholder, owning 63.33M shares representing 317.70% of the company. Bvf Partners L P's Ligand Pharmaceuticals shares are currently valued at $18.21B.

If you're new to stock investing, here's how to buy Ligand Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.